Dyslipidemia refers to unhealthy changes in blood lipid composition and is a risk factor for
atherosclerotic cardiovascular diseases (ASCVD). Usually, low-density lipoprotein …

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death and it has
been confirmed that increased low density lipoprotein cholesterol (LDL-C) is an …

Background In cholesterol guidelines, low-density lipoprotein (LDL) cholesterol remains the
primary target while apolipoprotein B (apoB) and non–high-density lipoprotein (non-HDL) …

Background: Apolipoprotein B (apoB) provides an integrated measure of atherogenic risk.
Whether apoB levels and apoB lowering hold incremental predictive information on residual …

Thyroid dysfunction, manifesting as either overt or subclinical hypothyroidism, negatively
affects lipid metabolism: this leads to hypercholesterolemia which progressively increases …

Abstract BACKGROUND The European Atherosclerosis Society–European Federation of
Clinical Chemistry and Laboratory Medicine Consensus Panel aims to provide …

Background The American Heart Association recognizes high triglycerides as a
cardiovascular risk factor. Methods and Results This retrospective observational …

Type 2 diabetes mellitus (T2DM) is characterized by multiple pathophysiologic
abnormalities. With time, multiple glucose-lowering medications are commonly required to …

Abstract Purpose of Review Treatment of hypercholesterolemia with statins results in
significant reductions in cardiovascular risk; however, individuals with well-controlled low …

Cholesterol crystalline domains characterize atherosclerotic membranes, altering vascular
signaling and function. Omega-3 fatty acids reduce membrane lipid peroxidation and …